Showing results (291-300 of 5,669) with videos related to

Sort By:
Pageof 567
The Oncologist|July 5, 2019
A Prospective Study of Sentinel Lymph Node Mapping for Endometrial Cancer: Is It Effective in High-Risk Subtypes?Lei Ye, ShuangDi Li, Wen Lu, et al.
The Oncologist|June 2, 2019
Navigating Challenging Conversations About Nonmedical Opioid Use in the Context of OncologyZachary Sager, Julie Childers
The Oncologist|June 26, 2019
Prospective Biomarker Study in Advanced RAS Wild-Type Colorectal Cancer: POSIBA Trial (GEMCAD 10-02)Xabier García-Albéniz, Vicente Alonso, Pilar Escudero, et al.
The Oncologist|July 12, 2019
Cumulative Antibiotic Use Significantly Decreases Efficacy of Checkpoint Inhibitors in Patients with Advanced CancerNadina Tinsley, Cong Zhou, Grace Tan, et al.
The Oncologist|October 10, 2019
A Phase I Trial Using a Multitargeted Recombinant Adenovirus 5 (CEA/MUC1/Brachyury)-Based Immunotherapy Vaccine Regimen in Patients with Advanced CancerMargaret E Gatti-Mays, Jason M Redman, Renee N Donahue, et al.
The Oncologist|March 11, 2022
Tyrosine Kinase Inhibitor Activity in Patients with NSCLC Harboring Uncommon EGFR Mutations: A Retrospective International Cohort Study (UpSwinG)Sanjay Popat, Te-Chun Hsia, Jen-Yu Hung, et al.
The Oncologist|March 11, 2022
Treatment Patterns, Health Care Resource Utilization, and Cost in Patients with Myelofibrosis in the United StatesRonda Copher, Arianna Kee, Aaron Gerds
The Oncologist|March 11, 2022
Sorafenib in Dupuytren and Ledderhose DiseaseJoshua D Schoenfeld, Narasimhan P Agaram, Robert A Lefkowitz, et al.
The Oncologist|March 11, 2022
Discordance in Tumor Mutation Burden from Blood and Tissue Affects Association with Response to Immune Checkpoint Inhibition in Real-World SettingsEmma G Sturgill, Amanda Misch, Carissa C Jones, et al.
The Oncologist|March 11, 2022
Complementary Medicine Use Amongst Patients with Metastatic Cancer Enrolled in Phase III Clinical TrialsJ Connor Wells, Aven Sidhu, Keyue Ding, et al.
Pageof 567